I did work with eye surgeons for many years and latterly they began to combine cataract surgery with a stent in perhaps 10 percent of patients. These were mainly general ophthalmologists but not glaucoma specialists. They are skilled but manage the stents well after tuition from the reps. With their skill the general eye surgeons should have no problem with the iTrack advance. It augurs well for the many thousands of eye surgeons world wide as distinct to the 200 surgeons we had on our books with the old tech.
Nova Eye Medical (EYE) Discussion, page-2452
Add EYE (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
24.0¢ |
Change
0.000(0.00%) |
Mkt cap ! $54.91M | |||
| Open | High | Low | Value | Volume |
| 24.0¢ | 24.0¢ | 24.0¢ | $22.71K | 94.64K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 342553 | 23.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 24.5¢ | 50000 | 1 |
View Market Depth
| Last trade - 10.28am 29/07/2024 (20 minute delay) ? |
| EYE (ASX) Chart |